Form 4: Pathfinder Bancorp SVP Robert Butkowski Jr. Reports Acquisition of Restricted Stock
SEC Form 4
Senior Vice President Robert G. Butkowski Jr. of Pathfinder Bancorp, Inc. reports acquiring 14,000 shares of restricted common stock on January 31, 2025, along with adjustments to existing holdings.
Summary
- Robert G. Butkowski Jr., a Senior Vice President at Pathfinder Bancorp, Inc., filed a Form 4 on February 4, 2025.
- The filing reports a transaction on January 31, 2025, where Butkowski acquired 14,000 shares of common stock.
- These shares were acquired as restricted stock, vesting at a rate of 25% per year starting January 31, 2026.
- Following the reported transaction, Butkowski directly owns 16,800 shares of common stock.
- Butkowski also indirectly owns 5,875 shares through an ESOP, 14,291 shares through a 401(k), and 6,500 shares through an IRA.
- He also holds 2,636 stock options with an exercise price of $11.35, expiring on May 6, 2026, and 1,500 stock options with an exercise price of $10.37, expiring on October 28, 2030.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing insider transactions. The acquisition of restricted stock could be interpreted as a slightly positive signal, but it's not definitively bullish.
Positives
- The acquisition of restricted stock by a senior executive could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting schedule of the restricted stock indicates a multi-year incentive for the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder confidence due to the executive's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 05/06/2017 | Date of stock options with an exercise price of $11.35 |
| 10/28/2021 | Date of stock options with an exercise price of $10.37 |
| 01/31/2025 | Date of transaction: Acquisition of 14,000 shares of restricted common stock |
| 01/31/2026 | Commencement date for vesting of restricted stock at a rate of 25% per year |
| 05/06/2026 | Expiration date for stock options with an exercise price of $11.35 |
| 10/28/2030 | Expiration date for stock options with an exercise price of $10.37 |
| 02/04/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.